Autor: "Tashiro M" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Novel Reassortant Avian Influenza A(H5N1) Virus in Human, Southern Vietnam, 2014.
Autorzy:: Takayama I
Hieu NT
Shirakura M
Nakauchi M
Fujisaki S
Takahashi H
Nagata S
Long NT
Odagiri T
Tashiro M
Kageyama T; Pokaż więcej
Źródło:: Emerging infectious diseases [Emerg Infect Dis] 2016 Mar; Vol. 22 (3), pp. 557-9.
Typ publikacji:: Case Reports; Letter; Research Support, Non-U.S. Gov't
MeSH Terms:: Reassortant Viruses*
Influenza A Virus, H5N1 Subtype/*classification
Influenza A Virus, H5N1 Subtype/*genetics
Influenza, Human/*diagnosis
Influenza, Human/*virology
Animals ; Genes, Viral ; Humans ; Influenza in Birds/epidemiology ; Influenza in Birds/virology ; Influenza, Human/epidemiology ; Influenza, Human/mortality ; Male ; Middle Aged ; Multilocus Sequence Typing ; Phylogeny ; Poultry/virology ; Vietnam/epidemiology

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Global circulation patterns of seasonal influenza viruses vary with antigenic drift.
Autorzy:: Bedford T; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Riley S; 1] MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London SW7 2AZ, UK [2] Fogarty International Center, National Institutes of Health, Bethesda, Maryland 20892, USA.
Barr IG; World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza, Melbourne, Victoria 3000, Australia.
Broor S; SGT Medical College, Hospital and Research Institute, Village Budhera, District Gurgaon, Haryana 122505, India.
Chadha M; National Institute of Virology, Pune 411001, India.
Cox NJ; WHO Collaborating Center for Reference and Research on Influenza, Centers for Disease Control and Prevention, Atlanta, Georgia 30329, USA.
Daniels RS; WHO Collaborating Center for Reference and Research on Influenza, Medical Research Council National Institute for Medical Research (NIMR), London NW7 1AA, UK.
Gunasekaran CP; King Institute of Preventive Medicine and Research, Guindy, Chennai 600032, India.
Hurt AC; 1] World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza, Melbourne, Victoria 3000, Australia [2] Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria 3010, Australia.
Kelso A; World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza, Melbourne, Victoria 3000, Australia.
Klimov A; WHO Collaborating Center for Reference and Research on Influenza, Centers for Disease Control and Prevention, Atlanta, Georgia 30329, USA.
Lewis NS; Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK.
Li X; WHO Collaborating Center for Reference and Research on Influenza, National Institute for Viral Disease Control and Prevention, China CDC, Beijing 102206, China.
McCauley JW; WHO Collaborating Center for Reference and Research on Influenza, Medical Research Council National Institute for Medical Research (NIMR), London NW7 1AA, UK.
Odagiri T; WHO Collaborating Center for Reference and Research on Influenza, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.
Potdar V; National Institute of Virology, Pune 411001, India.
Rambaut A; 1] Fogarty International Center, National Institutes of Health, Bethesda, Maryland 20892, USA [2] Institute of Evolutionary Biology, University of Edinburgh, Edinburgh EH9 3JT, UK [3] Centre for Immunology, Infection and Evolution, University of Edinburgh, Edinburgh EH9 3FL, UK.
Shu Y; WHO Collaborating Center for Reference and Research on Influenza, National Institute for Viral Disease Control and Prevention, China CDC, Beijing 102206, China.
Skepner E; Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK.
Smith DJ; 1] Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK [2] Department of Viroscience, Erasmus Medical Center, 3015 Rotterdam, The Netherlands.
Suchard MA; 1] Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles, California 90095, USA [2] Department of Biomathematics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California 90095, USA [3] Department of Human Genetics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California 90095, USA.
Tashiro M; WHO Collaborating Center for Reference and Research on Influenza, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.
Wang D; WHO Collaborating Center for Reference and Research on Influenza, National Institute for Viral Disease Control and Prevention, China CDC, Beijing 102206, China.
Xu X; WHO Collaborating Center for Reference and Research on Influenza, Centers for Disease Control and Prevention, Atlanta, Georgia 30329, USA.
Lemey P; Department of Microbiology and Immunology, Rega Institute, KU Leuven - University of Leuven, 3000 Leuven, Belgium.
Russell CA; Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, UK.; Pokaż więcej
Źródło:: Nature [Nature] 2015 Jul 09; Vol. 523 (7559), pp. 217-20. Date of Electronic Publication: 2015 Jun 08.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:: Antigenic Variation*
Influenza A virus/*genetics
Influenza B virus/*genetics
Influenza, Human/*epidemiology
Influenza, Human/*virology
Age Factors ; Global Health ; Humans ; Influenza A virus/classification ; Influenza B virus/classification ; Phylogeny ; Phylogeography ; Seasons

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Development of a sensitive novel diagnostic kit for the highly pathogenic avian influenza A (H5N1) virus.
Autorzy:: Tsunetsugu-Yokota Y; Department of Immunology, National Institute of Infectious Diseases, Shinjuku Tokyo 162-8640, Japan. .
Nishimura K
Misawa S
Kobayashi-Ishihara M
Takahashi H
Takayama I
Ohnishi K
Itamura S
Nguyen HL
Le MT
Dang GT
Nguyen LT
Tashiro M
Kageyama T; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2014 Jul 03; Vol. 14, pp. 362. Date of Electronic Publication: 2014 Jul 03.
Typ publikacji:: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Influenza A Virus, H5N1 Subtype/*isolation & purification
Influenza, Human/*virology
Humans ; Immunoenzyme Techniques ; Pharynx/virology ; Reagent Kits, Diagnostic ; Sensitivity and Specificity ; Vietnam

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Characterization of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post-pandemic periods in Japan.
Autorzy:: Takashita E; Laboratory of Influenza Virus Surveillance, Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Fujisaki S
Kishida N
Xu H
Imai M
Tashiro M
Odagiri T; Pokaż więcej
Corporate Authors:: Influenza Virus Surveillance Group of Japan
Źródło:: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2013 Nov; Vol. 7 (6), pp. 1390-9. Date of Electronic Publication: 2013 Jun 08.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Drug Resistance, Viral*
Antiviral Agents/*pharmacology
Influenza A Virus, H1N1 Subtype/*drug effects
Influenza, Human/*virology
Neuraminidase/*genetics
Viral Proteins/*genetics
Acids, Carbocyclic ; Alleles ; Cyclopentanes/pharmacology ; Enzyme Inhibitors/pharmacology ; Genotype ; Guanidines/pharmacology ; Humans ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H1N1 Subtype/isolation & purification ; Influenza, Human/epidemiology ; Japan/epidemiology ; Neuraminidase/antagonists & inhibitors ; Oseltamivir/pharmacology ; Pandemics ; RNA, Viral/genetics ; Sequence Analysis, DNA ; Viral Proteins/antagonists & inhibitors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Characterization of H7N9 influenza A viruses isolated from humans.
Autorzy:: Watanabe T; ERATO Infection-Induced Host Responses Project, Japan Science and Technology Agency, Saitama 332-0012, Japan.
Kiso M
Fukuyama S
Nakajima N
Imai M
Yamada S
Murakami S
Yamayoshi S
Iwatsuki-Horimoto K
Sakoda Y
Takashita E
McBride R
Noda T
Hatta M
Imai H
Zhao D
Kishida N
Shirakura M
de Vries RP
Shichinohe S
Okamatsu M
Tamura T
Tomita Y
Fujimoto N
Goto K
Katsura H
Kawakami E
Ishikawa I
Watanabe S
Ito M
Sakai-Tagawa Y
Sugita Y
Uraki R
Yamaji R
Eisfeld AJ
Zhong G
Fan S
Ping J
Maher EA
Hanson A
Uchida Y
Saito T
Ozawa M
Neumann G
Kida H
Odagiri T
Paulson JC
Hasegawa H
Tashiro M
Kawaoka Y; Pokaż więcej
Źródło:: Nature [Nature] 2013 Sep 26; Vol. 501 (7468), pp. 551-5. Date of Electronic Publication: 2013 Jul 10.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Influenza A virus*/chemistry
Influenza A virus*/drug effects
Influenza A virus*/isolation & purification
Influenza A virus*/pathogenicity
Virus Replication*/drug effects
Influenza, Human/*virology
Orthomyxoviridae Infections/*virology
Animals ; Antiviral Agents/pharmacology ; Cells, Cultured ; Chickens/virology ; DNA-Directed RNA Polymerases/antagonists & inhibitors ; Dogs ; Enzyme Inhibitors/pharmacology ; Female ; Ferrets/virology ; Humans ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/enzymology ; Influenza, Human/drug therapy ; Macaca fascicularis/virology ; Madin Darby Canine Kidney Cells ; Male ; Mice ; Mice, Inbred BALB C ; Models, Molecular ; Monkey Diseases/pathology ; Monkey Diseases/virology ; Neuraminidase/antagonists & inhibitors ; Orthomyxoviridae Infections/pathology ; Orthomyxoviridae Infections/transmission ; Quail/virology ; Swine/virology ; Swine, Miniature/virology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.
Autorzy:: Ampofo WK; National Influenza Centre, Accra, Ghana.
Baylor N; Food and Drug Administration, Rockville, MA, USA.
Cobey S; Harvard School of Public Health, Boston, MA, USA.
Cox NJ; Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Daves S; NAMRU-3, Cairo, Egypt.
Edwards S; Network of Expertise on Animal Influenzas(OFFLU) Steering Committee, Hereford, UK.
Ferguson N; Imperial College School of Medicine at St Mary's, London, UK.
Grohmann G; Therapeutic Goods Administration Laboratories, Symonston, Australia.
Hay A; National Institute for Medical Research, London, UK.
Katz J; Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Kullabutr K; Ministry of Public Health, Nonthaburi, Thailand.
Lambert L; National Institutes of Health, Bethesda, MD, USA.
Levandowski R; Freelancer, Bethesda, MD, USA.
Mishra AC; National Influenza Centre, Pune, India.
Monto A; University of Michigan School of Public Health, AnnArbor, MI, USA.
Siqueira M; Instituto Oswaldo Cruz, Rio de Janeiro, Brazil.
Tashiro M; WHO Collaborating Centre for Reference and Research on Influenza, Tokyo, Japan.
Waddell AL; Freelancer, Stanley, UK.
Wairagkar N; World Health Organization(WHO), Geneva, Switzerland.
Wood J; National Institute for Biological Standards and Control(NIBSC), PottersBar, UK.
Zambon M; Health Protection Agency, London, UK.
Zhang W; World Health Organization(WHO), Geneva, Switzerland.; Pokaż więcej
Corporate Authors:: WHO Writing Group
Źródło:: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2013 Sep; Vol. 7 Suppl 2, pp. 52-53.
Typ publikacji:: Journal Article
MeSH Terms:: Influenza Vaccines/*immunology
Influenza Vaccines/*isolation & purification
Influenza, Human/*epidemiology
Influenza, Human/*virology
Orthomyxoviridae/*immunology
Orthomyxoviridae/*isolation & purification
Epidemiological Monitoring ; Humans ; Influenza, Human/prevention & control ; Technology, Pharmaceutical